Navigation Links
Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) Annual Meeting
Date:11/1/2009

The incidence of skin adverse events (rash or pruritus) observed in the boceprevir arms was similar to that seen in the PEGINTRON and REBETOL control arm. Anemia occurred in approximately half of the patients in the boceprevir arms and over a third of patients in the control arm. Erythropoietin (EPO) supplementation was allowed in the study at the discretion of the investigator with concomitant ribavirin dose reduction and was used for 26 percent of patients in the control arm and 39-51 percent of patients in the boceprevir arms with standard-dose REBETOL.

Treatment discontinuations due to adverse events were between 9 and 19 percent for patients in the boceprevir arms, compared to 8 percent for the control arm. Treatment discontinuations in the boceprevir arms due to viral breakthrough were fewer in the 28- and 48-week lead-in arms (4 and 5 percent, respectively) compared to the no lead-in arms (7 and 12 percent, respectively).

About the HCV SPRINT-1 Study

In the Phase II HCV SPRINT-1 (HCV Serine Protease Inhibitor Therapy-1) study, boceprevir (800 mg TID) was evaluated in three treatment regimens: 4 weeks of PEGINTRON (1.5 mcg/kg once weekly) and REBETOL (800-1400 mg daily based on patient weight) therapy followed by the addition of boceprevir to the combination for 24 or 44 weeks (totaling 28 or 48 weeks of treatment), boceprevir in combination with PEGINTRON and REBETOL at the doses described above for 28 or 48 weeks, and, in Part II of the study, boceprevir in combination with PEGINTRON and low-dose REBETOL (400-1000 mg daily based on patient weight) for 48 weeks. In Part I of the study, the boceprevir regimens were compared to a control of PEGINTRON (1.5 mcg/kg once weekly) and REBETOL (800-1400 mg daily based on patient weight) alone for 48 weeks (an approved treatment regimen). In Part II of the study, boceprevir in combination with PEGINTRON and low-dose REBETOL for 48 weeks was compared to a contemporaneous contro
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Canary Foundation Commits to Supporting New Platform for Cancer Diagnostics
2. Food 4 Less Stores Giving Hope a Hand(R) in October by Supporting Breast Cancer Awareness Initiatives
3. Ralphs Stores Giving Hope a Hand(R) in October by Supporting Breast Cancer Awareness Initiatives
4. AstraZeneca Accepts Secretary of Defense Award for Supporting Employees Serving in National Guard and Reserve
5. Anthem Blue Cross and Blue Shield Foundation Grant Supporting American Diabetes Associations Family Link Program In Connecticut
6. livethesource(TM) Hosts Company Launch Event While Supporting The Brent Shapiro Foundations Annual Sober Night Out
7. CMSA Announces New Model ACT Supporting Case Management Programs
8. Hospice Foundation of America Presents New Educational Webinar on Supporting People with Intellectual Disabilities through Illness, Grief and Loss
9. The Sensory Research Center (SRC) Offers 2 for 1 Tickets for Benefit Concert Supporting Autism, Downs Syndrome, Cerebral Palsy and Other Disabilities.
10. Trust for Americas Health Praises Major Foundations for Supporting Prevention as a Central Part of Health Reform
11. American Humane Association Launches Innovative Therapy Animals Supporting Kids (TASK)(TM) Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Oregon (PRWEB) December 24, 2014 ... Rehab sat down with Derek Fenwick, PT, MBA, ... changes that will stem from the passing of the ... (IMPACT Act). In this taping of the Infinicast, ... title XVIII of the Social Security Act to standardize ...
(Date:12/24/2014)... Dec. 24, 2014 (HealthDay News) -- A new, injectable ... and Drug Administration. The agency on Tuesday approved ... those who are overweight and have at least one ... 2 diabetes or high cholesterol. Patients taking the ... low-calorie diet and exercise regularly, the FDA noted. ...
(Date:12/24/2014)... HealthDay Reporter TUESDAY, Dec. ... Diabetes Association (ADA) call for giving the cholesterol-lowering drugs known ... heart disease. These new standards bring the association in ... Association, which also recommend giving low- or high-dose statins to ... diabetes. "We agree that the decision to start a ...
(Date:12/24/2014)... 24, 2014 The 2014 Market ... professional and in-depth research report on COC industry. ... basic information, including its definition, classification, application, industry ... etc. This report also presents product specification, manufacturing ... separated by regions, technology and applications. Analysis also ...
(Date:12/24/2014)... Dental implants benefit millions of individuals ... They offer the strongest and most secure hold for ... of tooth replacement. They will never slip out of ... for support, and they prevent the jaw from shrinking ... they are not suitable candidates for dental implants because ...
Breaking Medicine News(10 mins):Health News:Latest Episode of Infinicast Features Infinity Rehab President Discussing IMPACT Act of 2014 and Changes for Post-Acute Therapy Providers in 2015 2Health News:FDA Approves New Weight-Loss Drug 2Health News:FDA Approves New Weight-Loss Drug 3Health News:Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts 2Health News:Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts 3Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 2Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 3Health News:Innovative Dental Implant Procedure to Gain Momentum in the New Year 2
... at Galveston researchers have achieved promising results with a ... common cause of infant hospitalization in the United States. ... therapy for RSV, the scientists tested two types of ... that RSV uses to replicate, or copy itself, within ...
... in New Public Service Advertisement ... ... and Brittany Lietz wanted was a dark tan. They thought it made,them ... they,would be battling melanoma, the deadliest form of skin cancer. Now Meghan,24, ...
... Needed to Prepare,for Future Disasters Especially on the Eve ... American Red Cross,today announced that it has met the ... its Disaster Relief Fund are still,needed to ensure it ... of hurricane season starting in less than a month., ...
... With spring in the air, most of,us ... that warm weather,brings -- flip flops, shorts, sunglasses, ... in sunscreen protection have become more,plentiful than ever, ... from ultraviolet (UV) light. Fortunately,dermatologists can help you ...
... License for Pulse!! Virtual Learning Platform for ... Clinical Skills and Decision Making Training, ... of,game-based technology solutions for training, experimentation and,decision-making analysis, has ... for the exclusive, worldwide rights to Pulse!! the,Virtual Clinical ...
... Floral Bouquet Purchased at, http://www.proflowers.com/CHF Will ... Ill., May 5 The Children,s Heart,Foundation today ... fresh flower marketplace -- just in time for ... http://www.proflowers.com/CHF and choose,from a variety of ...
Cached Medicine News:Health News:New agent strikes at respiratory syncytial virus replication 2Health News:Indoor Tanning is Not as Safe as You Think. In Fact, It's Totally Out: 2Health News:Indoor Tanning is Not as Safe as You Think. In Fact, It's Totally Out: 3Health News:Indoor Tanning is Not as Safe as You Think. In Fact, It's Totally Out: 4Health News:Generous Donors Allow Red Cross to Respond Swiftly and Effectively to Southeastern Virginia Tornadoes 2Health News:Generous Donors Allow Red Cross to Respond Swiftly and Effectively to Southeastern Virginia Tornadoes 3Health News:Recent Advances Make Sunscreen More Effective and Easier to Use 2Health News:Recent Advances Make Sunscreen More Effective and Easier to Use 3Health News:Recent Advances Make Sunscreen More Effective and Easier to Use 4Health News:Recent Advances Make Sunscreen More Effective and Easier to Use 5Health News:Recent Advances Make Sunscreen More Effective and Easier to Use 6Health News:Game-Based Technology to Meet Demand for Improved Medical Teaching and Training 2Health News:Game-Based Technology to Meet Demand for Improved Medical Teaching and Training 3Health News:The Children's Heart Foundation Teams Up With ProFlowers(R) to Raise Awareness and Funding for the Leading Birth Defect in America 2Health News:The Children's Heart Foundation Teams Up With ProFlowers(R) to Raise Awareness and Funding for the Leading Birth Defect in America 3
(Date:12/24/2014)... DIEGO , Dec. 23, 2014 ResMed (NYSE: ... significant patent infringement action against Chinese medical device manufacturer BMC ... (ITC) ruled today that BMC,s masks listed below infringe ResMed,s ... or selling these masks in the United States ... iVolve N2 nasal mask , Willow nasal pillows mask ...
(Date:12/24/2014)... , Dec. 23, 2014   Assurex Health, ... decision support to healthcare providers for behavioral health ... has secured $30 million in equity financing from ... C. Drosos , President and Chief Executive Officer. ... adoption and development of Assurex Health,s GeneSight ...
(Date:12/24/2014)... , Dec. 23, 2014 Tianyin Pharmaceutical ... that specializes in patented biopharmaceutical, modernized traditional Chinese ... (API) today announced that the Company achieved the ... Manufacturing Practice (GMP) certificate of TPI,s Qionglai Facility ... (CFDA). The public notice period is a significant ...
Breaking Medicine Technology:ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3
... 5, 2011 Reportlinker.com announces that ... available in its catalogue: ... Assessments of Leading Suppliers ... This report provides industry executives with ...
... 5, 2011 Reportlinker.com announces that a new ... China In Vitro Diagnostics ... http://www.reportlinker.com/p0240263/China-In-Vitro-Diagnostics-Market-Outlook-to-2016.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic China In Vitro ... Summary GlobalData,s new report, "China ...
Cached Medicine Technology:Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers 2Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers 3Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers 4Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers 5Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers 6Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers 7China In Vitro Diagnostics Market Outlook to 2016 2China In Vitro Diagnostics Market Outlook to 2016 3China In Vitro Diagnostics Market Outlook to 2016 4China In Vitro Diagnostics Market Outlook to 2016 5China In Vitro Diagnostics Market Outlook to 2016 6China In Vitro Diagnostics Market Outlook to 2016 7China In Vitro Diagnostics Market Outlook to 2016 8China In Vitro Diagnostics Market Outlook to 2016 9China In Vitro Diagnostics Market Outlook to 2016 10China In Vitro Diagnostics Market Outlook to 2016 11China In Vitro Diagnostics Market Outlook to 2016 12China In Vitro Diagnostics Market Outlook to 2016 13China In Vitro Diagnostics Market Outlook to 2016 14China In Vitro Diagnostics Market Outlook to 2016 15China In Vitro Diagnostics Market Outlook to 2016 16
... the first intra-operative fluorescent imaging system ... the location of the coronary arteries ... coronary artery bypass procedures. ,The patented ... to view, record, replay, print, and ...
... When myocardial infarction is ... TROPT sensitive rapid assay allows ... marker troponin T from a ... qualitative result is available within ...
The Polygraf ID multi-parametric recorder works with POLYGRAM NET analysis software to create a unique interface that combines web-style navigation, graphical presentation and intuitive design to del...
... The White Sun light source offers the industry ... Kelvin color temperature at a lower price. A ... White Sun to be used with Olympus, Storz, ... light output LED and re-settable bulb timer. The ...
Medicine Products: